Julie Kim, CEO-elect, is to be proposed as a candidate for the Board of Directors and Representative Director, President and ...

Eli Lilly (Lilly) has agreee to acquire Centessa Pharmaceuticals in a deal worth up to $7.8bn. Centessa is a clinical-stage ...

Caregivers are vital to clinical trial retention, yet often overlooked—this article highlights their challenges, impact, and ...

Biogen has agreed to acquire Apellis Pharmaceuticals for approximately $5.6bn.

LEO Pharma, a company focused on medical dermatology, has appointed Matt Ferriday as General Manager for LEO Pharma UK. Matt ...

Gilead has agreed to acquire Tubulis, a private, clinical-stage biotechnology company focused on developing next-generation ...

Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for ...

Eli Lilly’s Foundayo (orforglipron), the only oral GLP-1 weight loss treatment that can be taken at any time of the day with no food or water restrictions, has been approved by ...

Novo Nordisk’s Awiqli (insulin icodec) has been approved by the US FDA as the first and only once-weekly, long-acting basal ...

Sandoz has partnered with Samsung Bioepis to broaden patient access to high-quality biosimilar medicines worldwide. The ...

When PharmaQuest returned at the World Evidence, Pricing and Access (EPA) Congress 2026, we examined whether the priorities ...